{HEAD ~ The invention} also comprises {TAIL ~ a pharmaceutical composition} comprising a first antibody or an antigen binding fragment thereof, and a second antibody, or an antigen binding fragment thereof, wherein the first antibody is an antibody of the invention, and the second antibody is an antibody that neutralizes hCMV infection 
{ HEAD ~ The invention } also comprises { TAIL ~ a pharmaceutical composition } comprising a first antibody or an antigen binding fragment thereof , and a second antibody , or an antigen binding fragment thereof , wherein the first antibody is an antibody of the invention , and the second antibody is an antibody that neutralizes hCMV infection
HEAD HEAD HEAD HEAD HEAD HEAD OTH REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH